Trading Signals: SONN Stock Price Prediction and Forecast (Mon. Aug. 24, 2015 - Thu. Apr. 30, 2020)(Sonnet BioTherapeutics Holdings, Inc.)
| SONN latest price $109.2000 (0.75%) ($104.0000 - $114.4000) on Tue. Dec. 27, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.67% (three month average) | RSI | 42 | Latest Price | $109.2000(0.75%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SONN declines -8.7% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support SONN advance at 0% a week (0% probability) IWN(17%) QQQ(17%) TBT(17%) XAR(17%) IWC(16%) | Factors Impacting SONN price | SONN will decline at least -2.835% in a week (0% probabilities). VCSH(-27%) LQD(-20%) TLT(-19%) VCIT(-15%) CEMB(-15%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.835% (StdDev 5.67%) | Hourly BBV | 0 () | Intraday Trend | 5% | | | |
|
1 - 5 Day Possible Target | $93.83(-14.08%) | Resistance Level | $121.97 | 5 Day Moving Average | $107.49(1.59%) | 10 Day Moving Average | $113.34(-3.65%) | 20 Day Moving Average | $121.97(-10.47%) | To recent high | -30% | To recent low | 5% | Market Cap | $1.005b | | | | Sonnet BioTherapeutics Holdings, Inc. engages in the development of biologic drugs with enhanced single or bispecific mechanisms. Its technology utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. The company was founded on April 1, 2020 and is headquartered in Princeton, New Jersey. |